Back

Utility of Soluble ST2 biomarker to predict recurrence after electrical cardioversion in patients with atrial fibrillation

29 August 2022 (13:15 - 14:00)
Organised by:
Congress Presentation Part of: Following disease progression by blood biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Laila Gonzalez-Melchor

Hospital Doctor Jose Molina Orosa, Arrecife, Las Palmas (Spain)

6 More presentations in this session

Presentation thumbnail
Coronary artery disease ameliorates extracellular vesicle lncRNA PUNISHER regulates angiogenic response and endothelial cells function via NFkB-dependent mechanism
Doctor M. Hosen (Bonn, DE)
Abstract Slides
Presentation thumbnail
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography
Doctor K. Ali (Dundee, GB)
Abstract Slides
Presentation thumbnail
The endoplasmic reticulum (ER) chaperone GRP78 is secreted during ER Stress and alleviates endothelial cell inflammation
Miss E. Repges (Bonn, DE)
Abstract Slides
Presentation thumbnail
Metabolic modulation as a common adaptive mechanism in patients with different subtypes of aortic valve stenosis
Doctor P. Bengel (Giessen, DE)
Abstract Slides
Presentation thumbnail
Cardiac troponin T degradation in end-stage renal disease patients appears to occur in vivo
Miss E. Denessen (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Following disease progression by blood biomarkers

The Event

Event poster

ESC Congress 2022

29 August 2022 13:15 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources